NCT07021196 The ICT Based Prescription of Physical Activity for Oncology Patients at Their Home
| NCT ID | NCT07021196 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Federico II University |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-07-17 |
| Primary Completion | 2025-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2024-07-17 with a primary completion date of 2025-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Study evaluating the efficacy of ICT-based prescription of physical activity in oncology patients
Eligibility Criteria
Inclusion Criteria: * Female patients affected by breast cancer eligible for adiuvant treatment * Male patients affected by prostatic cancer eligible for adiuvant treatment Exclusion Criteria: * Active life stily before enrollment
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07021196 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07021196 currently recruiting?
Yes, NCT07021196 is actively recruiting participants. Contact the research team at afa.federico2@gmail.com for enrollment information.
Where is the NCT07021196 trial being conducted?
This trial is being conducted at Naples, Italy.
Who is sponsoring the NCT07021196 clinical trial?
NCT07021196 is sponsored by Federico II University. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.